5.20
price down icon4.59%   -0.25
pre-market  Vorhandelsmarkt:  5.04   -0.16   -3.08%
loading

Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
21.82%
3.7521
3.0802 3.3084 2.6542 2.5514
Operating Expenses
21.20%
5.311
4.3819 4.5021 3.9398 3.7749
Interest Income/Expense
1.11%
0.1247
0.1233 0.126 0.126 0.1247
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
21.20%
5.311
4.3819 4.5021 3.9398 3.7749
Provision For Loan, Lease, And Other Losses
-
- - - -
Operating Income/Loss
19.75%
-1.5589
-1.3017 -1.1937 -1.2857 -1.2236
Income/Loss From Continuing Operations Before Tax
387.26%
3.7521
-1.3062 3.3084 2.6542 -1.2672
Income/Loss From Continuing Operations After Tax
20.27%
-1.571
-1.3062 -1.1928 -1.3124 -1.2672
Net Income/Loss
20.27%
-1.571
-1.3062 -1.1928 -1.3124 -1.2672
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.18%
2.5532
2.5487 0.5234 1.3999 1.3635
Diluted Average Shares
0.18%
2.5532
2.5487 0.5234 1.3999 1.3635
Basic Earnings Per Share
21.57%
-0.62
-0.51 0.20 -0.94 -0.93
Diluted Earnings Per Share
21.57%
-0.62
-0.51 0.20 -0.94 -0.93
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$29.40
price up icon 1.48%
$17.85
price down icon 2.72%
drug_manufacturers_specialty_generic RDY
$14.12
price down icon 0.56%
$10.56
price up icon 0.09%
$141.92
price up icon 1.66%
$404.81
price up icon 32.83%
Kapitalisierung:     |  Volumen (24h):